» Articles » PMID: 31852802

Biocompatible Near-infrared Quantum Dots Delivered to the Skin by Microneedle Patches Record Vaccination

Abstract

Accurate medical recordkeeping is a major challenge in many low-resource settings where well-maintained centralized databases do not exist, contributing to 1.5 million vaccine-preventable deaths annually. Here, we present an approach to encode medical history on a patient using the spatial distribution of biocompatible, near-infrared quantum dots (NIR QDs) in the dermis. QDs are invisible to the naked eye yet detectable when exposed to NIR light. QDs with a copper indium selenide core and aluminum-doped zinc sulfide shell were tuned to emit in the NIR spectrum by controlling stoichiometry and shelling time. The formulation showing the greatest resistance to photobleaching after simulated sunlight exposure (5-year equivalence) through pigmented human skin was encapsulated in microparticles for use in vivo. In parallel, microneedle geometry was optimized in silico and validated ex vivo using porcine and synthetic human skin. QD-containing microparticles were then embedded in dissolvable microneedles and administered to rats with or without a vaccine. Longitudinal in vivo imaging using a smartphone adapted to detect NIR light demonstrated that microneedle-delivered QD patterns remained bright and could be accurately identified using a machine learning algorithm 9 months after application. In addition, codelivery with inactivated poliovirus vaccine produced neutralizing antibody titers above the threshold considered protective. These findings suggest that intradermal QDs can be used to reliably encode information and can be delivered with a vaccine, which may be particularly valuable in the developing world and open up new avenues for decentralized data storage and biosensing.

Citing Articles

On-patient medical record and mRNA therapeutics using intradermal microneedles.

Han J, Kanelli M, Liu Y, Daristotle J, Pardeshi A, Forster T Nat Mater. 2025; .

PMID: 39994390 DOI: 10.1038/s41563-024-02115-4.


Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.

Sergeeva O, Luo L, Guiseppi-Elie A Front Bioeng Biotechnol. 2025; 12:1499474.

PMID: 39898278 PMC: 11782185. DOI: 10.3389/fbioe.2024.1499474.


Polymeric Microneedle Drug Delivery Systems: Mechanisms of Treatment, Material Properties, and Clinical Applications-A Comprehensive Review.

Liu Y, Mao R, Han S, Yu Z, Xu B, Xu T Polymers (Basel). 2024; 16(18).

PMID: 39339032 PMC: 11434959. DOI: 10.3390/polym16182568.


Toxicologic Pathology Forum: mRNA Vaccine Safety-Separating Fact From Fiction.

Sellers R, Dormitzer P Toxicol Pathol. 2024; 52(6):333-342.

PMID: 39254115 PMC: 11528946. DOI: 10.1177/01926233241278298.


Delivery of luminescent particles to plants for information encoding and storage.

Li W, Lin J, Huang W, Wang Q, Zhang H, Zhang X Light Sci Appl. 2024; 13(1):217.

PMID: 39198416 PMC: 11358502. DOI: 10.1038/s41377-024-01518-x.


References
1.
Westphal D, Eastwood A, Levy A, Davies J, Huppatz C, Gilles M . A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Lancet Infect Dis. 2018; 19(2):177-184. DOI: 10.1016/S1473-3099(18)30498-5. View

2.
Lo Vecchio A, Cambriglia M, Fedele M, Basile F, Chiatto F, Miraglia Del Giudice M . Determinants of low measles vaccination coverage in children living in an endemic area. Eur J Pediatr. 2018; 178(2):243-251. DOI: 10.1007/s00431-018-3289-5. View

3.
Praestmark K, Jensen M, Madsen N, Kildegaard J, Stallknecht B . Pen needle design influences ease of insertion, pain, and skin trauma in subjects with type 2 diabetes. BMJ Open Diabetes Res Care. 2017; 4(1):e000266. PMC: 5174793. DOI: 10.1136/bmjdrc-2016-000266. View

4.
Lerner R . Limitations in the use of dielectric interference filters in wide angle optical receivers. Appl Opt. 2010; 10(8):1914-8. DOI: 10.1364/AO.10.001914. View

5.
Masid M, Ocana R, Gil M, Ramos M, Roig M, Carreno M . A patient care program for adjusting the autoinjector needle depth according to subcutaneous tissue thickness in patients with multiple sclerosis receiving subcutaneous injections of glatiramer acetate. J Neurosci Nurs. 2014; 47(1):E22-30. PMC: 4334306. DOI: 10.1097/JNN.0000000000000086. View